本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apimeds Pharmaceutical U.S, Inc.

1.75
-0.0600-3.31%
盘前1.66-0.0900-5.14%06:19 EDT
成交量:45.17万
成交额:73.77万
市值:2,025.01万
市盈率:-9.95
高:1.83
开:1.81
低:1.44
收:1.81
数据加载中...
2025/05/12

重要事件披露

Form 8-K - Current report
2025/05/02

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/04/15

重要事件披露

Form 8-K - Current report
2025/02/10

SEC问询函

Form CORRESP - Correspondence
2025/02/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/02/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/08

SEC问询函

Form CORRESP - Correspondence
2025/02/08

SEC问询函

Form CORRESP - Correspondence
2025/02/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/20

SEC问询函

Form CORRESP - Correspondence
2024/12/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/11/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/25

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933